Replies to post #150224 on Biotech Values

[ghmm]

I am not sure if this was a rhetorical question or not. Here are a couple links to pubmed searches
http://www.ncbi.nlm.nih.gov/pubmed?term=immunoglobulin%20%20alzheimer%27s
http://www.ncbi.nlm.nih.gov/pubmed?term=ivig%20alzheimer%27s

EDIT:
I should point out part of my thesis for its potential is the aggregate of multiple possible pathways. I am not convinced that blocking AB's toxicity alone can be enough to show benefit at least in this stage of the disease.